142 related articles for article (PubMed ID: 27588395)
41. RING finger protein 38 induces gastric cancer cell growth by decreasing the stability of the protein tyrosine phosphatase SHP-1.
Zhang J; Wu H; Yi B; Zhou J; Wei L; Chen Y; Zhang L
FEBS Lett; 2018 Sep; 592(18):3092-3100. PubMed ID: 30112836
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
[TBL] [Abstract][Full Text] [Related]
43. Downregulation of Wilms' tumor gene (WT1) is not a prerequisite for erythroid or megakaryocytic differentiation of the leukemic cell line K562.
Svedberg H; Chylicki K; Gullberg U
Exp Hematol; 1999 Jun; 27(6):1057-62. PubMed ID: 10378895
[TBL] [Abstract][Full Text] [Related]
44. Long noncoding RNA HOTAIR promotes the self-renewal of leukemia stem cells through epigenetic silencing of p15.
Gao S; Zhou B; Li H; Huang X; Wu Y; Xing C; Yu X; Ji Y
Exp Hematol; 2018 Nov; 67():32-40.e3. PubMed ID: 30172749
[TBL] [Abstract][Full Text] [Related]
45. Silencing of TGIF attenuates the tumorigenicity of A549 cells in vitro and in vivo.
Wang Y; Pan T; Wang H; Li L; Li J; Zhang C; Yang H
Tumour Biol; 2016 Sep; 37(9):12725-12730. PubMed ID: 27448304
[TBL] [Abstract][Full Text] [Related]
46. Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphoma.
Kinoshita S; Ishida T; Ito A; Narita T; Masaki A; Suzuki S; Yoshida T; Ri M; Kusumoto S; Komatsu H; Shimizu N; Inagaki H; Kuroda T; Scholz A; Ueda R; Sanda T; Iida S
Haematologica; 2018 Dec; 103(12):2059-2068. PubMed ID: 30076184
[TBL] [Abstract][Full Text] [Related]
47. Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer.
Zhao F; Lin T; He W; Han J; Zhu D; Hu K; Li W; Zheng Z; Huang J; Xie W
Oncotarget; 2015 Jan; 6(2):1064-78. PubMed ID: 25473900
[TBL] [Abstract][Full Text] [Related]
48. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
49. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
[TBL] [Abstract][Full Text] [Related]
50. Cooperation of MLL/AF10(OM-LZ) with PTPN11 activating mutation induced monocytic leukemia with a shorter latency in a mouse bone marrow transplantation model.
Fu JF; Liang ST; Huang YJ; Liang KH; Yen TH; Liang DC; Shih LY
Int J Cancer; 2017 Mar; 140(5):1159-1172. PubMed ID: 27859216
[TBL] [Abstract][Full Text] [Related]
51. Silencing of argininosuccinate lyase inhibits colorectal cancer formation.
Huang HL; Chen WC; Hsu HP; Cho CY; Hung YH; Wang CY; Lai MD
Oncol Rep; 2017 Jan; 37(1):163-170. PubMed ID: 27840980
[TBL] [Abstract][Full Text] [Related]
52. Oncogenic heterogeneous nuclear ribonucleoprotein D-like promotes the growth of human colon cancer SW620 cells via its regulation of cell-cycle.
Zhang P; Ji D; Hu X; Ni H; Ma W; Zhang X; Liao S; Zeng Z; Zhao Y; Zhou H
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):880-887. PubMed ID: 30052712
[TBL] [Abstract][Full Text] [Related]
53. Abnormal expression of TGF-beta type II receptor isoforms contributes to acute myeloid leukemia.
Wu Y; Su M; Zhang S; Cheng Y; Liao XY; Lin BY; Chen YZ
Oncotarget; 2017 Feb; 8(6):10037-10049. PubMed ID: 28052022
[TBL] [Abstract][Full Text] [Related]
54. RING finger protein 10 regulates retinoic acid-induced neuronal differentiation and the cell cycle exit of P19 embryonic carcinoma cells.
Malik YS; Sheikh MA; Lai M; Cao R; Zhu X
J Cell Biochem; 2013 Sep; 114(9):2007-15. PubMed ID: 23526782
[TBL] [Abstract][Full Text] [Related]
55. Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program.
Svedberg H; Chylicki K; Baldetorp B; Rauscher FJ; Gullberg U
Oncogene; 1998 Feb; 16(7):925-32. PubMed ID: 9484784
[TBL] [Abstract][Full Text] [Related]
56. Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction.
Fogal V; Babic I; Chao Y; Pastorino S; Mukthavaram R; Jiang P; Cho YJ; Pingle SC; Crawford JR; Piccioni DE; Kesari S
Oncotarget; 2015 Jan; 6(2):1157-70. PubMed ID: 25528767
[TBL] [Abstract][Full Text] [Related]
57. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros.
Greif PA; Tizazu B; Krause A; Kremmer E; Bohlander SK
Oncogene; 2008 May; 27(20):2886-96. PubMed ID: 18037964
[TBL] [Abstract][Full Text] [Related]
58. Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia.
Zeng C; Yu X; Lai J; Yang L; Chen S; Li Y
J Hematol Oncol; 2015 Nov; 8():126. PubMed ID: 26545364
[TBL] [Abstract][Full Text] [Related]
59. SNHG6 is upregulated in primary breast cancers and promotes cell cycle progression in breast cancer-derived cell lines.
Jafari-Oliayi A; Asadi MH
Cell Oncol (Dordr); 2019 Apr; 42(2):211-221. PubMed ID: 30826970
[TBL] [Abstract][Full Text] [Related]
60. Key contribution of eIF4H-mediated translational control in tumor promotion.
Vaysse C; Philippe C; Martineau Y; Quelen C; Hieblot C; Renaud C; Nicaise Y; Desquesnes A; Pannese M; Filleron T; Escourrou G; Lawson M; Rintoul RC; Delisle MB; Pyronnet S; Brousset P; Prats H; Touriol C
Oncotarget; 2015 Nov; 6(37):39924-40. PubMed ID: 26498689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
